NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development ...
16hon MSN
With shares up more than 333% over the last 12 months, Palantir Technologies (NASDAQ: PLTR) has been a massive beneficiary of ...
Kadimastem’s attempt to vault onto Nasdaq is picking up momentum, with shareholders signing off on a merger with NLS Pharmaceutics that would enable the cell therapy developer to recover from last ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback